Truist Securities Reiterates Aptinyx (APTX) at Buy, Downside is Limited, While Upside Could be Significant

February 10, 2022 7:20 AM EST Send to a Friend
Truist Securities analyst Joon Lee reiterated a Buy rating and $12.00 price target on Aptinyx (NASDAQ: APTX)The analyst quotes: "While ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login